Langseth MS, Opstad TB, Bratseth V, et al. Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease. Eur J Prev Cardiol 2018; 25: 762–769.
2.
LiaoXNorataGDPolakJFet al.Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin?Eur J Prev Cardiol2016; 23: 1165–1173.
3.
WilleitPThompsonSGAgewallSet al.Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration. Eur J Prev Cardiol2016; 23: 194–205.
4.
Wu Y, Sun D, Wang B, et al. The relationship of depressive symptoms and functional and structural markers of subclinical atherosclerosis: A systematic review and meta-analysis. Eur J Prev Cardiol 2018; 25: 706–716.
5.
Nielsen SH, Mygind ND, Michelsen MM, et al. Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy. Eur J Prev Cardiol 2018; 25: 719–727.
6.
GorenekBPellicciaABenjaminEJet al.European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Eur J Prev Cardiol2017; 24: 4–40.
7.
MourtzinisGErydSARosengrenAet al.Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide case–control study. Eur J Prev Cardiol2018; 25: 694–701.
8.
RauchBDavosCHDohertyPet al.The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies – The Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol2016; 23: 1914–1939.
9.
PiepoliMFHoesAWAgewallSet al.European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Prev Cardiol2016; 23: NP1–NP96.
10.
KotsevaKDe BacquerDDe BackerGet al.Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol2016; 23: 2007–2018.
11.
HansenDDendalePConinxKet al.The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol2017; 24: 1017–1031.
12.
Hansen D, Rovelo Ruiz G, Doherty P, et al. Do clinicians prescribe exercise similarly in patients with different cardiovascular diseases? Findings from the EAPC EXPERT* working group survey. Eur J Prev Cardiol 2018; 25: 682–691.
13.
Gomes-NetoMDurãesARReisHFCDet al.High intensity interval training versus moderate-intensity continuous training on exercise capacity and quality of life in patients with coronary artery disease: A systematic review and meta-analysis. Eur J Prev Cardiol2017; 24: 1696–1707.
14.
SatoTYoshihisaAKannoYet al.Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction. Eur J Prev Cardiol2017; 24: 1979–1987.
15.
de Souza e Silva CG, Kaminsky LA, Arena R, et al. A reference equation for maximal aerobic power for treadmill and cycle ergometer exercise testing: Analysis from the FRIEND registry. Eur J Prevent Cardiol 2018; 25: 742–750.
16.
ZafrirB. The prognostic value of exercise testing: exercise capacity, hemodynamic response, and cardio-metabolic risk factors. Eur J Prev Cardiol2017; 24: 1624–1626.
17.
LaukkanenJASoares de AraùjoCGKurlSet al.Relative peak exercise oxygen pulse is related to sudden cardiac death, cardiovascular and all-cause mortality in middle-aged men. Eur J Prev Cardiol2018; 25: 772–782.
18.
Kato YSS, Uejima T, Semba H, et al. Relationship between the prognostic value of ventilator efficiency and age in patients with heart failure. Eur J Prev Cardiol 2018; 25: 731–739.
19.
Guazzi M. Adjusting exercise ventilation efficiency for age: A step forward for optimizing prediction of outcome especially in heart failure with preserved ejection fraction. Eur J Prev Cardiol 2018; 25: 728–730.
